Ionis Pharmaceuticals: Jefferies cuts target price to $61 from $80
IONS•Jefferies cut its target price for Ionis Pharmaceuticals to $61 from $80.
Related News
BT to hold off Starlink launch until Ukraine 'noise' dies down, CEO says
BTI•
Dropbox announces upsize and pricing of $1.1 billion convertible notes offering
DBX•
Robotaxi wars will end in Uber-Waymo union
UBER•
Palomar Holdings, Inc.: KBW raises target price to $172 from $161
PLMR•
Philip Morris: JPMorgan reinstates coverage with neutral rating; target price $200
PM•